Evidence for Actin Cytoskeleton-dependent and -independent Pathways for RelA/p65 Nuclear Translocation in Endothelial Cells*
- Departments of ‡Pediatrics and §Biomedical Engineering, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642
- 1 To whom correspondence should be addressed: Dept. of Pediatrics, Box 850, 601 Elmwood Ave., Rochester, NY 14642. Tel.: 585-275-5948; Fax: 585-756-7780; E-mail: Arshad_Rahman{at}urmc.rochester.edu.
Abstract
Activation of the transcription factor NF-κB involves its release from the inhibitory protein IκBα in the cytoplasm and subsequently, its translocation to the nucleus. Whereas the events responsible for its release have been elucidated, mechanisms regulating the nuclear transport of NF-κB remain elusive. We now provide evidence for actin cytoskeleton-dependent and -independent mechanisms of RelA/p65 nuclear transport using the proinflammatory mediators, thrombin and tumor necrosis factor α, respectively. We demonstrate that thrombin alters the actin cytoskeleton in endothelial cells and interfering with these alterations, whether by stabilizing or destabilizing the actin filaments, prevents thrombin-induced NF-κB activation and consequently, expression of its target gene, ICAM-1. The blockade of NF-κB activation occurs downstream of IκBα degradation and is associated with impaired RelA/p65 nuclear translocation. Importantly, thrombin induces association of RelA/p65 with actin and this interaction is sensitive to stabilization/destabilization of the actin filaments. In parallel studies, stabilizing or destabilizing the actin filaments fails to inhibit RelA/p65 nuclear accumulation and ICAM-1 expression by tumor necrosis factor α, consistent with its inability to induce actin filament formation comparable with thrombin. Thus, these studies reveal the existence of actin cytoskeleton-dependent and -independent pathways that may be engaged in a stimulus-specific manner to facilitate RelA/p65 nuclear import and thereby ICAM-1 expression in endothelial cells.
Footnotes
-
↵2 The abbreviations used are: NF-κB, nuclear factor-κB; HUVEC, human umbilical vein endothelial cells; ICAM-1, intercellular adhesion molecule-1; IKK, IκB kinase; LUC, luciferase; PBS, phosphate-buffered saline; TNFα, tumor necrosis factor α; ROCK, Rho-associated kinase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Cyto D, cytochalasin D; Lat B, latrunculin B; Jas, jasplakinolide.
-
↵3 F. Fazal, unpublished observation.
-
↵* This work was supported by National Institutes of Health NHLBI Grant HL67424. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Received August 22, 2006.
- Revision received November 16, 2006.
- The American Society for Biochemistry and Molecular Biology, Inc.











